Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New agents for cataracts designed by Sankyo

May 22, 2000

Squalamine demonstrates preclinical activity in retinopathy

May 19, 2000

Ciba Vision and QLT expand strategic alliance for developing new treatments for eye diseases

May 16, 2000

Special access program approved for Visudyne in Canada

May 11, 2000

Bausch & Lomb reports progress with breakthrough treatment for serious eye diseases

May 11, 2000

Akorn obtains rights to AMD technology

May 9, 2000

Known antianginal agent claimed for use in retinal diseases by French researchers

May 9, 2000

Preliminary phase II results for Optin in AMD

May 9, 2000

Actin polymerization inducer jasplakinolide improves outflow facility in primate model

May 5, 2000

News from ARVO: ISV-205 reduces corticosteroid-induced IOP elevations

May 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...